Search Orphan Drug Designations and Approvals
-
Generic Name: | Botulinum toxin type A | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Botox | ||||||||||||||||
Date Designated: | 08/20/1986 | ||||||||||||||||
Orphan Designation: | Treatment of cervical dystonia. | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Allergan, Inc. 2525 Dupont Drive P.O. Box 19534 Irvine, California 92623 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | Botulinum toxin type A |
---|---|---|
Trade Name: | Botox | |
Marketing Approval Date: | 12/21/2000 | |
Approved Labeled Indication: | Treatment of cervical dystonia in adults to decrease the severity of abnormal head position and neck pain associated with cervical dystonia. | |
Exclusivity End Date: | 12/21/2007 | |
Exclusivity Protected Indication* : | ||
-